Rank | Gene Set | Z-score |
---|---|---|
1 | central nervous system myelination (GO:0022010) | 8.08426414 |
2 | axon ensheathment in central nervous system (GO:0032291) | 8.08426414 |
3 | presynaptic membrane organization (GO:0097090) | 5.91388317 |
4 | locomotory exploration behavior (GO:0035641) | 4.87051676 |
5 | presynaptic membrane assembly (GO:0097105) | 4.85257892 |
6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.70606883 |
7 | synaptic vesicle maturation (GO:0016188) | 4.56015395 |
8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.37892460 |
9 | neuron cell-cell adhesion (GO:0007158) | 4.28594570 |
10 | L-amino acid import (GO:0043092) | 4.27254586 |
11 | glutamate secretion (GO:0014047) | 4.00118697 |
12 | cellular potassium ion homeostasis (GO:0030007) | 3.90309749 |
13 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.82579726 |
14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.65320781 |
15 | neurotransmitter uptake (GO:0001504) | 3.63763594 |
16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.61530136 |
17 | righting reflex (GO:0060013) | 3.55988478 |
18 | postsynaptic membrane organization (GO:0001941) | 3.53263868 |
19 | myelin maintenance (GO:0043217) | 3.51542898 |
20 | potassium ion import (GO:0010107) | 3.50012537 |
21 | amino acid import (GO:0043090) | 3.47722890 |
22 | exploration behavior (GO:0035640) | 3.44139261 |
23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.44014780 |
24 | vocalization behavior (GO:0071625) | 3.40759786 |
25 | myelination (GO:0042552) | 3.34022443 |
26 | ensheathment of neurons (GO:0007272) | 3.32263670 |
27 | axon ensheathment (GO:0008366) | 3.32263670 |
28 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.28478512 |
29 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.26036179 |
30 | glutamate receptor signaling pathway (GO:0007215) | 3.24253295 |
31 | sodium ion export (GO:0071436) | 3.24072973 |
32 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.20885894 |
33 | synaptic transmission, glutamatergic (GO:0035249) | 3.18875197 |
34 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.18825029 |
35 | neuronal ion channel clustering (GO:0045161) | 3.16821348 |
36 | neuronal action potential propagation (GO:0019227) | 3.15530914 |
37 | neurotransmitter secretion (GO:0007269) | 3.13895791 |
38 | potassium ion homeostasis (GO:0055075) | 3.11132052 |
39 | neuron-neuron synaptic transmission (GO:0007270) | 3.09312561 |
40 | synaptic vesicle exocytosis (GO:0016079) | 3.01867577 |
41 | long-term synaptic potentiation (GO:0060291) | 3.00808657 |
42 | detection of calcium ion (GO:0005513) | 2.95926667 |
43 | transmission of nerve impulse (GO:0019226) | 2.90330918 |
44 | substantia nigra development (GO:0021762) | 2.90257219 |
45 | C4-dicarboxylate transport (GO:0015740) | 2.89586908 |
46 | neurotransmitter transport (GO:0006836) | 2.86935275 |
47 | acidic amino acid transport (GO:0015800) | 2.84933187 |
48 | astrocyte development (GO:0014002) | 2.81552603 |
49 | oligodendrocyte differentiation (GO:0048709) | 2.81335997 |
50 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.81092585 |
51 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.79946536 |
52 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.79887157 |
53 | positive regulation of neurological system process (GO:0031646) | 2.78474508 |
54 | proline transport (GO:0015824) | 2.77189965 |
55 | serotonin metabolic process (GO:0042428) | 2.73008775 |
56 | regulation of synaptic vesicle transport (GO:1902803) | 2.70185240 |
57 | cyclic nucleotide catabolic process (GO:0009214) | 2.69485886 |
58 | glycerophospholipid catabolic process (GO:0046475) | 2.68304734 |
59 | gamma-aminobutyric acid transport (GO:0015812) | 2.68145773 |
60 | peptidyl-cysteine modification (GO:0018198) | 2.63638039 |
61 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.62226988 |
62 | primary amino compound metabolic process (GO:1901160) | 2.62108563 |
63 | regulation of dendritic spine development (GO:0060998) | 2.61800799 |
64 | startle response (GO:0001964) | 2.60161335 |
65 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.60063769 |
66 | L-glutamate transport (GO:0015813) | 2.58956553 |
67 | regulation of female receptivity (GO:0045924) | 2.54002490 |
68 | regulation of neurotransmitter levels (GO:0001505) | 2.51762016 |
69 | astrocyte differentiation (GO:0048708) | 2.48969099 |
70 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.47886489 |
71 | dendritic spine morphogenesis (GO:0060997) | 2.47691996 |
72 | regulation of neurotransmitter uptake (GO:0051580) | 2.47454767 |
73 | membrane depolarization during action potential (GO:0086010) | 2.46885514 |
74 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.46753002 |
75 | cellular sodium ion homeostasis (GO:0006883) | 2.46194703 |
76 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.44092585 |
77 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.43117001 |
78 | regulation of synaptic plasticity (GO:0048167) | 2.42799492 |
79 | regulation of neuron projection regeneration (GO:0070570) | 2.42554854 |
80 | regulation of axon regeneration (GO:0048679) | 2.42554854 |
81 | regulation of neurotransmitter transport (GO:0051588) | 2.39558128 |
82 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.38815687 |
83 | potassium ion transmembrane transport (GO:0071805) | 2.38716353 |
84 | cellular potassium ion transport (GO:0071804) | 2.38716353 |
85 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.38441553 |
86 | membrane assembly (GO:0071709) | 2.38229168 |
87 | long term synaptic depression (GO:0060292) | 2.37686768 |
88 | cell communication involved in cardiac conduction (GO:0086065) | 2.36883061 |
89 | regulation of postsynaptic membrane potential (GO:0060078) | 2.36654080 |
90 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.36645147 |
91 | L-fucose catabolic process (GO:0042355) | 2.35592035 |
92 | fucose catabolic process (GO:0019317) | 2.35592035 |
93 | L-fucose metabolic process (GO:0042354) | 2.35592035 |
94 | potassium ion transport (GO:0006813) | 2.34815784 |
95 | negative regulation of dendrite development (GO:2000171) | 2.33856755 |
96 | atrial cardiac muscle cell action potential (GO:0086014) | 2.32680061 |
97 | adult walking behavior (GO:0007628) | 2.32166862 |
98 | positive regulation of membrane potential (GO:0045838) | 2.31940574 |
99 | positive regulation of dendritic spine development (GO:0060999) | 2.31557206 |
100 | positive regulation of meiosis (GO:0045836) | 2.31548124 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.72908654 |
2 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.62030741 |
3 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.58493751 |
4 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.39255739 |
5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.33800924 |
6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.32875023 |
7 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.32861256 |
8 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.28244003 |
9 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.26251726 |
10 | P300_19829295_ChIP-Seq_ESCs_Human | 2.23752163 |
11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.19495048 |
12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.17945856 |
13 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17785956 |
14 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.14061526 |
15 | FUS_26573619_Chip-Seq_HEK293_Human | 2.11075040 |
16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04356930 |
17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.03464010 |
18 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.01210050 |
19 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.92530025 |
20 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.92058016 |
21 | STAT3_23295773_ChIP-Seq_U87_Human | 1.87244068 |
22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.86492924 |
23 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.84974898 |
24 | EWS_26573619_Chip-Seq_HEK293_Human | 1.83276991 |
25 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.82858564 |
26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.80398403 |
27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.78243763 |
28 | TCF4_23295773_ChIP-Seq_U87_Human | 1.76334672 |
29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.74982867 |
30 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.69687579 |
31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68365017 |
32 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.63769805 |
33 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.63216969 |
34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.62691832 |
35 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.57183832 |
36 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.54483011 |
37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54024261 |
38 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.51310022 |
39 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.49978094 |
40 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.49182001 |
41 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.48241356 |
42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47867922 |
43 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.46565760 |
44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.45939031 |
45 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43156861 |
46 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.42143121 |
47 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38788662 |
48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38379407 |
49 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.36624093 |
50 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.34878336 |
51 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34472614 |
52 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.32583267 |
53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31862350 |
54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31192353 |
55 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.30459264 |
56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30091179 |
57 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.27663649 |
58 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.27036775 |
59 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.26131859 |
60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.25565635 |
61 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25323860 |
62 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24440420 |
63 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.23382630 |
64 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.23371643 |
65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22571154 |
66 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.21607777 |
67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.21391217 |
68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.21391217 |
69 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.20470087 |
70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20449180 |
71 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20357995 |
72 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.19379063 |
73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.18313511 |
74 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.16926543 |
75 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.16761352 |
76 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.15496726 |
77 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15329716 |
78 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15308603 |
79 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.14366506 |
80 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14023715 |
81 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.13628966 |
82 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.13316199 |
83 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13316199 |
84 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.12176042 |
85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12055012 |
86 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11319331 |
87 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11319331 |
88 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09746739 |
89 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.09366300 |
90 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09068470 |
91 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08995795 |
92 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08517620 |
93 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.08178220 |
94 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.08167135 |
95 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.07141897 |
96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06512964 |
97 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.05822079 |
98 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.05690271 |
99 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04810276 |
100 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04512446 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004270_analgesia | 3.92211118 |
2 | MP0004859_abnormal_synaptic_plasticity | 3.75961656 |
3 | MP0003880_abnormal_central_pattern | 3.08631540 |
4 | MP0001968_abnormal_touch/_nociception | 2.91844310 |
5 | MP0002064_seizures | 2.91431133 |
6 | MP0002736_abnormal_nociception_after | 2.88245263 |
7 | MP0001486_abnormal_startle_reflex | 2.86122855 |
8 | MP0002272_abnormal_nervous_system | 2.81692621 |
9 | MP0003635_abnormal_synaptic_transmissio | 2.62043486 |
10 | MP0000920_abnormal_myelination | 2.61638540 |
11 | MP0004885_abnormal_endolymph | 2.59285434 |
12 | MP0009046_muscle_twitch | 2.57441137 |
13 | MP0009745_abnormal_behavioral_response | 2.54376723 |
14 | MP0002734_abnormal_mechanical_nocicepti | 2.46190552 |
15 | MP0003690_abnormal_glial_cell | 2.34405551 |
16 | MP0005423_abnormal_somatic_nervous | 2.17261040 |
17 | MP0001501_abnormal_sleep_pattern | 2.16287591 |
18 | MP0002063_abnormal_learning/memory/cond | 2.09390100 |
19 | MP0002735_abnormal_chemical_nociception | 2.04959230 |
20 | MP0008057_abnormal_DNA_replication | 2.00514809 |
21 | MP0009780_abnormal_chondrocyte_physiolo | 1.96824116 |
22 | MP0003787_abnormal_imprinting | 1.93063276 |
23 | MP0002572_abnormal_emotion/affect_behav | 1.89501033 |
24 | MP0001984_abnormal_olfaction | 1.89278859 |
25 | MP0008877_abnormal_DNA_methylation | 1.77082485 |
26 | MP0004147_increased_porphyrin_level | 1.76004688 |
27 | MP0001970_abnormal_pain_threshold | 1.73970898 |
28 | MP0001485_abnormal_pinna_reflex | 1.73525823 |
29 | MP0005646_abnormal_pituitary_gland | 1.69099238 |
30 | MP0005551_abnormal_eye_electrophysiolog | 1.62456711 |
31 | MP0001529_abnormal_vocalization | 1.57516301 |
32 | MP0010678_abnormal_skin_adnexa | 1.56334548 |
33 | MP0002733_abnormal_thermal_nociception | 1.53116589 |
34 | MP0008569_lethality_at_weaning | 1.52462325 |
35 | MP0002229_neurodegeneration | 1.45725936 |
36 | MP0002067_abnormal_sensory_capabilities | 1.43383508 |
37 | MP0003633_abnormal_nervous_system | 1.42778842 |
38 | MP0000383_abnormal_hair_follicle | 1.41602511 |
39 | MP0003632_abnormal_nervous_system | 1.38312776 |
40 | MP0002909_abnormal_adrenal_gland | 1.36436480 |
41 | MP0002557_abnormal_social/conspecific_i | 1.35561424 |
42 | MP0000778_abnormal_nervous_system | 1.35288425 |
43 | MP0003123_paternal_imprinting | 1.32534339 |
44 | MP0003631_nervous_system_phenotype | 1.26804003 |
45 | MP0004924_abnormal_behavior | 1.26598269 |
46 | MP0005386_behavior/neurological_phenoty | 1.26598269 |
47 | MP0004742_abnormal_vestibular_system | 1.25932553 |
48 | MP0003879_abnormal_hair_cell | 1.24969430 |
49 | MP0001440_abnormal_grooming_behavior | 1.22411713 |
50 | MP0003634_abnormal_glial_cell | 1.21802490 |
51 | MP0003195_calcinosis | 1.19797783 |
52 | MP0010234_abnormal_vibrissa_follicle | 1.16908252 |
53 | MP0002066_abnormal_motor_capabilities/c | 1.15821133 |
54 | MP0004043_abnormal_pH_regulation | 1.15751545 |
55 | MP0002882_abnormal_neuron_morphology | 1.11074980 |
56 | MP0003718_maternal_effect | 1.11026476 |
57 | MP0000427_abnormal_hair_cycle | 1.06938044 |
58 | MP0001963_abnormal_hearing_physiology | 1.05038999 |
59 | MP0000955_abnormal_spinal_cord | 1.03880370 |
60 | MP0006276_abnormal_autonomic_nervous | 1.03326080 |
61 | MP0008872_abnormal_physiological_respon | 1.02684400 |
62 | MP0001986_abnormal_taste_sensitivity | 1.02369669 |
63 | MP0005253_abnormal_eye_physiology | 1.01670934 |
64 | MP0005645_abnormal_hypothalamus_physiol | 1.00887208 |
65 | MP0004811_abnormal_neuron_physiology | 1.00773667 |
66 | MP0001177_atelectasis | 1.00729787 |
67 | MP0001905_abnormal_dopamine_level | 0.97689208 |
68 | MP0004142_abnormal_muscle_tone | 0.93610096 |
69 | MP0001188_hyperpigmentation | 0.93031343 |
70 | MP0001502_abnormal_circadian_rhythm | 0.92838532 |
71 | MP0000631_abnormal_neuroendocrine_gland | 0.90777155 |
72 | MP0010386_abnormal_urinary_bladder | 0.90017183 |
73 | MP0004215_abnormal_myocardial_fiber | 0.88455714 |
74 | MP0005379_endocrine/exocrine_gland_phen | 0.85926815 |
75 | MP0003283_abnormal_digestive_organ | 0.85203959 |
76 | MP0000569_abnormal_digit_pigmentation | 0.85169972 |
77 | MP0001346_abnormal_lacrimal_gland | 0.83334676 |
78 | MP0002876_abnormal_thyroid_physiology | 0.81928182 |
79 | MP0004019_abnormal_vitamin_homeostasis | 0.81741123 |
80 | MP0002152_abnormal_brain_morphology | 0.81426487 |
81 | MP0000579_abnormal_nail_morphology | 0.80658830 |
82 | MP0003136_yellow_coat_color | 0.78948937 |
83 | MP0003121_genomic_imprinting | 0.78640414 |
84 | MP0002254_reproductive_system_inflammat | 0.76995777 |
85 | MP0010352_gastrointestinal_tract_polyps | 0.75901507 |
86 | MP0003119_abnormal_digestive_system | 0.75250219 |
87 | MP0002752_abnormal_somatic_nervous | 0.73182543 |
88 | MP0000647_abnormal_sebaceous_gland | 0.72856395 |
89 | MP0002069_abnormal_eating/drinking_beha | 0.72165940 |
90 | MP0002090_abnormal_vision | 0.70100003 |
91 | MP0002184_abnormal_innervation | 0.70063682 |
92 | MP0002638_abnormal_pupillary_reflex | 0.68646108 |
93 | MP0003329_amyloid_beta_deposits | 0.68505252 |
94 | MP0001666_abnormal_nutrient_absorption | 0.68377490 |
95 | MP0010094_abnormal_chromosome_stability | 0.67796521 |
96 | MP0001756_abnormal_urination | 0.66928273 |
97 | MP0002938_white_spotting | 0.66764803 |
98 | MP0005174_abnormal_tail_pigmentation | 0.65009917 |
99 | MP0005360_urolithiasis | 0.64872175 |
100 | MP0005171_absent_coat_pigmentation | 0.64036628 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 4.61094761 |
2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.48826002 |
3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.48826002 |
4 | Action tremor (HP:0002345) | 4.03679617 |
5 | Focal seizures (HP:0007359) | 3.83115231 |
6 | Abnormality of the corticospinal tract (HP:0002492) | 3.78859597 |
7 | Increased circulating renin level (HP:0000848) | 3.47174545 |
8 | Gaze-evoked nystagmus (HP:0000640) | 3.40259225 |
9 | Febrile seizures (HP:0002373) | 3.27482261 |
10 | Scanning speech (HP:0002168) | 3.20361037 |
11 | Myokymia (HP:0002411) | 3.03789206 |
12 | Epileptic encephalopathy (HP:0200134) | 3.03749231 |
13 | Metabolic alkalosis (HP:0200114) | 3.02254373 |
14 | Intention tremor (HP:0002080) | 2.93613354 |
15 | Generalized tonic-clonic seizures (HP:0002069) | 2.91080427 |
16 | Atonic seizures (HP:0010819) | 2.86527756 |
17 | Hyperventilation (HP:0002883) | 2.80552022 |
18 | Cerebral hypomyelination (HP:0006808) | 2.76816744 |
19 | Spastic gait (HP:0002064) | 2.73996433 |
20 | Ankle clonus (HP:0011448) | 2.66381133 |
21 | Dysmetria (HP:0001310) | 2.66137005 |
22 | Dialeptic seizures (HP:0011146) | 2.61988251 |
23 | Hypomagnesemia (HP:0002917) | 2.61646544 |
24 | Progressive cerebellar ataxia (HP:0002073) | 2.59299883 |
25 | Dysdiadochokinesis (HP:0002075) | 2.57061483 |
26 | Broad-based gait (HP:0002136) | 2.56936257 |
27 | Abnormality of the labia minora (HP:0012880) | 2.48890304 |
28 | Absent speech (HP:0001344) | 2.38649202 |
29 | Epileptiform EEG discharges (HP:0011182) | 2.38589526 |
30 | Hemiparesis (HP:0001269) | 2.38127372 |
31 | Confusion (HP:0001289) | 2.36060793 |
32 | Abnormality of renin-angiotensin system (HP:0000847) | 2.33433658 |
33 | Leukodystrophy (HP:0002415) | 2.28218532 |
34 | Absence seizures (HP:0002121) | 2.26968165 |
35 | Hypoglycemic seizures (HP:0002173) | 2.26353547 |
36 | Hyperaldosteronism (HP:0000859) | 2.24686583 |
37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.24463147 |
38 | Abnormal eating behavior (HP:0100738) | 2.21932802 |
39 | Abnormality of vitamin B metabolism (HP:0004340) | 2.20054746 |
40 | Choreoathetosis (HP:0001266) | 2.17927418 |
41 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17375072 |
42 | Abolished electroretinogram (ERG) (HP:0000550) | 2.15964171 |
43 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.12600062 |
44 | Abnormality of magnesium homeostasis (HP:0004921) | 2.10714650 |
45 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.10267602 |
46 | Morphological abnormality of the inner ear (HP:0011390) | 2.08685058 |
47 | Hypsarrhythmia (HP:0002521) | 2.08117414 |
48 | Astrocytoma (HP:0009592) | 2.04732068 |
49 | Abnormality of the astrocytes (HP:0100707) | 2.04732068 |
50 | Lower limb muscle weakness (HP:0007340) | 2.03999752 |
51 | Alacrima (HP:0000522) | 2.01292044 |
52 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.01047861 |
53 | Congenital sensorineural hearing impairment (HP:0008527) | 2.00718763 |
54 | Spastic tetraparesis (HP:0001285) | 1.97587838 |
55 | Abnormal auditory evoked potentials (HP:0006958) | 1.97185395 |
56 | Volvulus (HP:0002580) | 1.92178499 |
57 | Urinary urgency (HP:0000012) | 1.91562145 |
58 | Neoplasm of the adrenal cortex (HP:0100641) | 1.90008900 |
59 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.89810841 |
60 | Abnormality of cochlea (HP:0000375) | 1.88602181 |
61 | Hypokalemic alkalosis (HP:0001949) | 1.87919272 |
62 | Embryonal renal neoplasm (HP:0011794) | 1.87604311 |
63 | Neoplasm of the oral cavity (HP:0100649) | 1.87305959 |
64 | Protruding tongue (HP:0010808) | 1.86325922 |
65 | Hypoglycemic coma (HP:0001325) | 1.84977552 |
66 | Glioma (HP:0009733) | 1.84497702 |
67 | Diplopia (HP:0000651) | 1.83856492 |
68 | Abnormality of binocular vision (HP:0011514) | 1.83856492 |
69 | Postural instability (HP:0002172) | 1.82790436 |
70 | Impaired vibratory sensation (HP:0002495) | 1.81205912 |
71 | Abnormality of vitamin metabolism (HP:0100508) | 1.80175545 |
72 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.79239795 |
73 | CNS hypomyelination (HP:0003429) | 1.78705302 |
74 | Aqueductal stenosis (HP:0002410) | 1.77378119 |
75 | Clonus (HP:0002169) | 1.75019282 |
76 | Hyperactive renin-angiotensin system (HP:0000841) | 1.74624568 |
77 | Sensory axonal neuropathy (HP:0003390) | 1.71371053 |
78 | Anxiety (HP:0000739) | 1.71352490 |
79 | Status epilepticus (HP:0002133) | 1.71067187 |
80 | Megalencephaly (HP:0001355) | 1.70969998 |
81 | Poor eye contact (HP:0000817) | 1.70743755 |
82 | Paraplegia (HP:0010550) | 1.69872561 |
83 | Drooling (HP:0002307) | 1.69666927 |
84 | Polydipsia (HP:0001959) | 1.67762016 |
85 | Abnormal drinking behavior (HP:0030082) | 1.67762016 |
86 | Limb dystonia (HP:0002451) | 1.67737054 |
87 | Dysmetric saccades (HP:0000641) | 1.67735944 |
88 | Decreased lacrimation (HP:0000633) | 1.67145979 |
89 | Urethral obstruction (HP:0000796) | 1.65688468 |
90 | Biliary tract neoplasm (HP:0100574) | 1.65581797 |
91 | Colon cancer (HP:0003003) | 1.64314578 |
92 | Stridor (HP:0010307) | 1.64088619 |
93 | Neoplasm of the small intestine (HP:0100833) | 1.63461588 |
94 | Abnormality of serum amino acid levels (HP:0003112) | 1.63160597 |
95 | Spastic paraplegia (HP:0001258) | 1.62069635 |
96 | Peripheral hypomyelination (HP:0007182) | 1.61884041 |
97 | Symptomatic seizures (HP:0011145) | 1.61601298 |
98 | Bell-shaped thorax (HP:0001591) | 1.61206142 |
99 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.60108627 |
100 | Truncal ataxia (HP:0002078) | 1.59914635 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 4.57435231 |
2 | CASK | 3.08254399 |
3 | NTRK3 | 2.85112383 |
4 | TNIK | 2.84279804 |
5 | UHMK1 | 2.66366036 |
6 | OXSR1 | 2.65995379 |
7 | STK39 | 2.48299796 |
8 | EPHA4 | 2.46912882 |
9 | FGFR2 | 2.46025703 |
10 | ACVR1B | 2.26090704 |
11 | DAPK2 | 1.99042693 |
12 | MKNK2 | 1.88613359 |
13 | PBK | 1.88116919 |
14 | MST4 | 1.82866968 |
15 | BMPR1B | 1.73067449 |
16 | MARK1 | 1.65189823 |
17 | PLK2 | 1.63110835 |
18 | TAF1 | 1.55487204 |
19 | WNK3 | 1.55123943 |
20 | MST1R | 1.50348883 |
21 | MET | 1.43611042 |
22 | MAP3K4 | 1.40961187 |
23 | CAMK2B | 1.38158750 |
24 | STK38L | 1.31810319 |
25 | ERBB3 | 1.26971356 |
26 | MINK1 | 1.26423769 |
27 | PLK3 | 1.26183255 |
28 | TRIM28 | 1.23007723 |
29 | PAK6 | 1.20592853 |
30 | PKN1 | 1.20321175 |
31 | NTRK2 | 1.19696242 |
32 | MAP3K9 | 1.16114446 |
33 | TTK | 1.14398114 |
34 | MKNK1 | 1.13485423 |
35 | INSRR | 1.09541328 |
36 | PINK1 | 1.06954289 |
37 | CAMK2D | 1.06387473 |
38 | PHKG2 | 1.05127857 |
39 | PHKG1 | 1.05127857 |
40 | NEK1 | 1.04333595 |
41 | MAP4K2 | 1.02132051 |
42 | DAPK1 | 1.00946082 |
43 | NEK6 | 1.00767745 |
44 | PRKCG | 1.00643664 |
45 | TSSK6 | 0.98206540 |
46 | CSNK1G1 | 0.96663301 |
47 | MAPK13 | 0.93598236 |
48 | CAMK2A | 0.93577560 |
49 | PRKCE | 0.92225399 |
50 | ZAK | 0.92175794 |
51 | PAK3 | 0.91111691 |
52 | CAMK2G | 0.90310293 |
53 | GRK1 | 0.87319912 |
54 | SGK2 | 0.86716729 |
55 | SGK223 | 0.86691487 |
56 | SGK494 | 0.86691487 |
57 | CDK5 | 0.84545157 |
58 | BUB1 | 0.81250685 |
59 | CSNK1G2 | 0.81128673 |
60 | ALK | 0.79681866 |
61 | BRSK1 | 0.79394536 |
62 | LMTK2 | 0.76171406 |
63 | MAPKAPK5 | 0.71554331 |
64 | PLK4 | 0.70068305 |
65 | BRSK2 | 0.69591781 |
66 | ROCK2 | 0.68270927 |
67 | WNK4 | 0.67209739 |
68 | YES1 | 0.66581895 |
69 | PNCK | 0.65344444 |
70 | PRKD3 | 0.64010428 |
71 | NUAK1 | 0.62505758 |
72 | BMPR2 | 0.61199191 |
73 | PLK1 | 0.59608769 |
74 | CSNK1A1L | 0.59453076 |
75 | NLK | 0.59217973 |
76 | SGK1 | 0.59088785 |
77 | CDC7 | 0.58596351 |
78 | MAP3K2 | 0.55060316 |
79 | CSNK1G3 | 0.53970691 |
80 | BCR | 0.53221916 |
81 | STK11 | 0.52279301 |
82 | CAMK1 | 0.50209278 |
83 | STK3 | 0.49779731 |
84 | CSNK1A1 | 0.49731634 |
85 | MAPK10 | 0.48369628 |
86 | SGK3 | 0.47378763 |
87 | CSNK1D | 0.46794396 |
88 | FGFR1 | 0.46231286 |
89 | DYRK1A | 0.45725159 |
90 | CAMK1G | 0.44905103 |
91 | RPS6KA3 | 0.44022301 |
92 | CSNK1E | 0.43737329 |
93 | PRKG1 | 0.43325480 |
94 | FER | 0.41985342 |
95 | NTRK1 | 0.40722506 |
96 | PRKCA | 0.40095333 |
97 | CDK18 | 0.39471725 |
98 | PRKG2 | 0.38475460 |
99 | PTK2B | 0.38466269 |
100 | ADRBK2 | 0.38310853 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.33832895 |
2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.63799063 |
3 | Histidine metabolism_Homo sapiens_hsa00340 | 2.48013090 |
4 | Insulin secretion_Homo sapiens_hsa04911 | 2.29745629 |
5 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.21765006 |
6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.14850643 |
7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.12037968 |
8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.04913019 |
9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.95515690 |
10 | GABAergic synapse_Homo sapiens_hsa04727 | 1.90845723 |
11 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.86308159 |
12 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76642621 |
13 | Morphine addiction_Homo sapiens_hsa05032 | 1.72233940 |
14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.71046267 |
15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.65710737 |
16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.57702880 |
17 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.56305640 |
18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.55114437 |
19 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.53619482 |
20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52300636 |
21 | Salivary secretion_Homo sapiens_hsa04970 | 1.52197202 |
22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.49614881 |
23 | Renin secretion_Homo sapiens_hsa04924 | 1.48717727 |
24 | Taste transduction_Homo sapiens_hsa04742 | 1.44700019 |
25 | Phototransduction_Homo sapiens_hsa04744 | 1.41266194 |
26 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.40388328 |
27 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.38621721 |
28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.37230433 |
29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.34968695 |
30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.34605554 |
31 | * Ether lipid metabolism_Homo sapiens_hsa00565 | 1.32381356 |
32 | Mineral absorption_Homo sapiens_hsa04978 | 1.32155730 |
33 | Long-term depression_Homo sapiens_hsa04730 | 1.26982945 |
34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.26249400 |
35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.25975623 |
36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24116626 |
37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20966616 |
38 | Bile secretion_Homo sapiens_hsa04976 | 1.19482404 |
39 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.19079042 |
40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.15477870 |
41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.13510125 |
42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.10982362 |
43 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.00776553 |
44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.00205395 |
45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.95674755 |
46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94555669 |
47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94523270 |
48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.90501694 |
49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90150695 |
50 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88799045 |
51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88667171 |
52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.88077753 |
53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87987938 |
54 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87805131 |
55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84750265 |
56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83843819 |
57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.81668205 |
58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80254548 |
59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76868003 |
60 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76323921 |
61 | Tight junction_Homo sapiens_hsa04530 | 0.75165563 |
62 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74869902 |
63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73743185 |
64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73333174 |
65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72641481 |
66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.72337117 |
67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71877204 |
68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71381294 |
69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.71250456 |
70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68180445 |
71 | ABC transporters_Homo sapiens_hsa02010 | 0.67041421 |
72 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65702739 |
73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64774182 |
74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62040443 |
75 | Homologous recombination_Homo sapiens_hsa03440 | 0.61114994 |
76 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58908196 |
77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58087962 |
78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58080569 |
79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57232543 |
80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56837151 |
81 | Lysine degradation_Homo sapiens_hsa00310 | 0.54793058 |
82 | Protein export_Homo sapiens_hsa03060 | 0.54232001 |
83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54008303 |
84 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52749446 |
85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51503032 |
86 | Gap junction_Homo sapiens_hsa04540 | 0.51227328 |
87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50373109 |
88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49765234 |
89 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49340209 |
90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48965795 |
91 | Mismatch repair_Homo sapiens_hsa03430 | 0.45578008 |
92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.44430699 |
93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43636404 |
94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41639351 |
95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41480497 |
96 | Peroxisome_Homo sapiens_hsa04146 | 0.40772277 |
97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40551070 |
98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39997608 |
99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39054020 |
100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38901533 |